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ABSTRACT 
 
Placental tumours are classified into trophoblastic and nontrophoblastic tumours. Nontrphoblastic tumours are 
relatively rare which includes chorioangioma/placental hemangioma, placental teratoma, placental metastatis. 
Chorioangioma has a prevalence of 1% among other placental tumours. Giant chorioangioma is relatively rare. 
Chorioangioma may be associated with adverse fetal and maternal complications. Fetal complications may include 
intrauterine fetal growth retardation, fetal anemia, polyhydramnios and maternal complications may include 
pregnancy induced hypertension, antepartum hemorrhage, preterm labour. Untoward complications can be avoided 
by timely detection, appropriate follow up and management. We report a case of giant chorioangioma and its 
outcome. 
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Introduction 
 
 
Placental tumours can be broadly classified into two types 
- trophoblastic and nontrophoblastic. Nontrophoblastic 
tumours are relatively rare which includes placental 
chorioangioma/hemangioma, placental teratoma, placental 
metastasis. Chorioangioma has a prevalence of 1% among 
other placental tumours1. There are very few case reports 
of giant chorioangioma. Giant chorioangioma may cause 
adverse fetal and maternal complications2. Fetal 
complications may include intrauterine fetal growth 
retardation, fetal anemia, polyhydramnios and maternal 
complications includes pregnancy induced hypertension, 
preeclamplsia, antepartum hemorrhage and preterm 
labour.  
 
Case History 
 
Case: We report a case of 25 year old primigravida in her 
third trimester at 35 weeks of gestation, referred to our 
department for obstetric ultrasound from gynecology 
department. Ultrasound scan revealed single live 
intrauterine gestation with cephalic presentation of 
biparietal diameter-, abdominal  
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Circumference-, femur length-, average gestational age 
and fetal weight-. Placenta was anterior and liquor 
adequate. Three vessel cords was demonstrated. On grey 
scale there was e/o 3.5 x 2.5 x 4 cm sized well defined 
hypoechoic lesion noted at cord insertion site [Figure 1] 
which on colour doppler showed peripheral vascularity 
[Figure 2]. Patient’s temperature, pulse and blood pressure 
were within normal limit. Patient was followed up to 37 
weeks of gestation at which she went into labour and gave 
birth to male baby by normal vaginal delivery. Baby 
weight was 3kg and cried immediately after birth. 
Macroscopically placenta measured 12 x 15 x 7 cm 
weighing around 1085gms. There was protruding lesion 
noted near cord insertion site. On histopathology shows 
diffuse proliferation of capillary sized vessel [Figure 3,4]. 
 
Discussion 
 
Chorioangioma is relatively rare benign tumour of 
placenta with a prevalence of 1% among other placental 
tumours1. Most chorioangiomas are small and are found 
incidentally at obstetric ultrasound. Chorioangioma 
originates from primitive chorionic mesenchyme. It 
develops when blood vessels and stroma proliferate 
independently of the surrounding tissue. 
Histopathologically chorioangioma is further divided into 
three types- angiomatous, cellular and degenerate2, 3, 4. 
The angiomatous pattern is most common chatecterised 
by abundant capillaries and blood vessels surrounded 
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by placental stroma. The cellular pattern has abundant 
endothelial cells within stroma. The degenerate pattern 
is characterized by calcification, necrosis or 
hyalinisation. Most authors consider chorioangioma as 
neoplasms, however these lesions are also classified as 
placental hamartomas by few5, 6. 
Chrioangioma may have clinical implications 
depending upon their size and vascularity. Giant 
chorioangioma (>4cms) are rare. They are associated 
with increased maternal age, diabetes mellitus and 
hypertension. Maternal complications may include 
pregnancy induced hypertension, preterm labour, 
antepartum hemorrhage and polyhydramnios. Of the 
various various complications preeclampsia and 
polyhydramnios have increased association. Fetal 
complications may include fetal congestive heart failure, 
intrauterine growth restriction, anemia, fetal 
thrombocytopenia and hydrops.Most cases of 
chorioangioma are diagnosed following delivery. Clark 
described the first case of chorioangioma in 19787 and 
first ultrasound diagnosis was also reported in the same 
period which made diagnosis and follow up possible 
following delivery.  Use of Doppler for differentiating 
chorioangioma from other lesions like hemorrhge, 
teratoma was first stated by Bromley and Benacerraf8 
However, increased alpha-fetoprotein or Beta hCG may 
cause suspicion9. Colour Doppler imaging helps 
differentiate chorioangioma from other lesions like 
fibroid, teratoma, hematoma but is useful in prenatal 
follow-up of these cases10. Eldar-Geva et al11 et al showed 
calcifications and tumour size reduction leads to 
improvement in clinical outcome. 
Placental chorioangioma can increase in size rapidly, 
leading to fetal heart failure, motoring and follow up 
Doppler is of paramount importance. We have shown the 
importance of sonography and Doppler study for 
diagnosis and follow up of placental chorioangioma. 
Larger chrioangiomas specially those more than 4cm may 
have bad prognosis hence early diagnosis and prompt 
follow up of pregnancies are necessary with ugrey scale 
and Doppler ultrasound studies. Giant chorioangioma is 
associated with adverse fetal outcomes which warrents 
timely detection, close follow up and institutional delivery 
as in our patient. 
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